- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 19.05. | Bone Biologics extends rhNELL-1 protein shelf life to 29 months | 1 | Investing.com | ||
| 19.05. | Bone Biologics verlängert Haltbarkeit von Protein rhNELL-1 auf 29 Monate | 1 | Investing.com Deutsch | ||
| BONE BIOLOGICS Aktie jetzt für 0€ handeln | |||||
| 14.05. | Bone Biologics Corp - 10-Q, Quarterly Report | 2 | SEC Filings | ||
| 13.03. | Bone Biologics kündigt 'At-the-Market'-Angebot über 1,06 Millionen US-Dollar an der NASDAQ an | 1 | Investing.com Deutsch | ||
| 13.03. | Bone Biologics Corp - 8-K, Current Report | 3 | SEC Filings | ||
| 02.03. | Bone Biologics Corp - 10-K, Annual Report | 3 | SEC Filings | ||
| 08.01. | BONE BIOLOGICS CORPORATION: Bone Biologics Highlights 2025 Key Operational, Scientific, and Corporate Milestones and Provides 2026 Outlook | 397 | GlobeNewswire (Europe) | BURLINGTON, Mass., Jan. 08, 2026 (GLOBE NEWSWIRE) -- Bone Biologics Corporation ("Bone Biologics" or the "Company") (NASDAQ: BBLG, BBLGW), a developer of orthobiologic products for spine fusion markets... ► Artikel lesen | |
| 08.01. | Bone Biologics Corp - 8-K, Current Report | - | SEC Filings | ||
| 23.12.25 | BONE BIOLOGICS CORPORATION: Bone Biologics Improves Extension of rhNELL-1 Product Shelf Life to 24 Months | 304 | GlobeNewswire (Europe) | BURLINGTON, Mass., Dec. 23, 2025 (GLOBE NEWSWIRE) -- Bone Biologics Corporation ("Bone Biologics" or the "Company") (NASDAQ: BBLG, BBLGW), a developer of orthobiologic products for spine fusion markets... ► Artikel lesen |
9 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| ATOSSA THERAPEUTICS | 1,770 | +3,51 % | Atossa Therapeutics Inc: Atossa Therapeutics Announces Closing of Registered Direct Offering of up to $16.5 Million in Gross Proceeds | $4.5 million upfront with up to an additional $12 million of potential aggregate gross proceeds upon exercise in full of warrants
SEATTLE, June 12, 2026 /PRNewswire/... ► Artikel lesen | |
| BEYOND AIR | 0,441 | -1,10 % | Beyond Air Reports Fourth Quarter and Full Year 2026 Financial Results and Provides Corporate Update | Revenue increased by 107% year-over-year to $7.7 million in the full fiscal year 2026; increased revenue by 66% YoY in the fiscal fourth quarter 2026 The Company is transitioning its year-end from... ► Artikel lesen | |
| ACCENDRA HEALTH | 2,960 | -1,33 % | ACCENDRA HEALTH INC/VA/ - 8-K, Current Report | ||
| AXOGEN | 39,900 | -1,34 % | Axogen, Inc.: Axogen Announces Pricing of Upsized $124 Million Public Offering of Common Stock | ALACHUA, Fla. and TAMPA, Fla., Jan. 21, 2026 (GLOBE NEWSWIRE) -- Axogen, Inc. (Nasdaq: AXGN), a global leader in developing and marketing innovative surgical solutions for the restoration of peripheral... ► Artikel lesen | |
| AETHLON MEDICAL | 0,815 | -1,01 % | Aethlon Medical study links device to Long COVID markers | ||
| AVANOS MEDICAL | 21,600 | -0,92 % | Avanos Medical, Inc. Announces First Quarter 2026 Results | Delivered double-digit organic growth led by Specialty Nutrition Systems segment
Generated $0.11 of diluted earnings per share and $0.22 of adjusted diluted earnings... ► Artikel lesen | |
| APYX MEDICAL | 3,860 | -4,93 % | Apyx Medical Corporation Receives Expanded FDA 510(k) Clearance Adding Power Liposuction Capability to AYON Body Contouring System | CLEARWATER Fla., May 11, 2026 (GLOBE NEWSWIRE) -- Apyx Medical Corporation (Nasdaq: APYX) (the "Company" or "Apyx Medical"), the leader in surgical aesthetics products marketed and sold as Renuvion... ► Artikel lesen | |
| ANGIODYNAMICS | 11,600 | 0,00 % | Reasons to Hold AngioDynamics Stock in Your Portfolio for Now | ||
| ENVUE MEDICAL | 0,515 | +0,02 % | ENvue Medical, Inc.: ENvue Medical Expands into Burn Intensive Care Unit at Major Academic Health Network | TYLER, Texas, June 05, 2026 (GLOBE NEWSWIRE) -- ENvue Medical (NASDAQ: FEED) ("ENvue," "ENvue Medical," or the "Company"), a commercial-stage medical device company focused on real-time guided bedside... ► Artikel lesen | |
| GLUCOTRACK | 0,315 | -1,16 % | GlucoTrack, Inc.: Glucotrack Reports First Quarter 2026 Financial Results and Recent Corporate Highlights | Submitted Investigational Device Exemption (IDE) application to the U.S. Food and Drug Administration (FDA) to initiate a U.S. clinical study for fully implantable continuous blood glucose monitoring... ► Artikel lesen | |
| BLUEJAY DIAGNOSTICS | 1,200 | 0,00 % | Morning Market Movers: Bluejay Diagnostics, Decent Holding, Abits Group, Sunshine Biopharma See Big Swings | WASHINGTON (dpa-AFX) - At 7:35 a.m. ET on Tuesday, premarket trading is seeing notable activity in several stocks, with early price movements signaling potential opportunities before the opening... ► Artikel lesen | |
| AUTONOMIX MEDICAL | 6,180 | -0,80 % | Autonomix Medical, Inc. - 8-K, Current Report | ||
| AESTHETIC MEDICAL INTERNATIONAL | 0,009 | 0,00 % | XFRA 3FMA,833: AUSSETZUNG/SUSPENSION | DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILAEST.MED.INT.HLD.SP.ADR/3... ► Artikel lesen | |
| ADVANCED BIOMED | 4,610 | +3,36 % | Advanced Biomed Inc. - 8-K, Current Report | ||
| AGAPE ATP | 2,950 | -0,34 % | Morning Market Movers: Intercont (Cayman), Agape ATP, Astrotech, Snowflake See Big Swings | TOKYO (dpa-AFX) - At 8:05 a.m. ET on Thursday, premarket trading is seeing notable activity in several stocks, with early price movements signaling potential opportunities before the opening... ► Artikel lesen |
BONE BIOLOGICS CORP gehört der Branche Gesundheitswesen an. Die relative Kursveränderung beträgt aktuell 0,00 % bei einem Aktienkurs von 1,370 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu BONE BIOLOGICS CORP finden Sie auf Wallstreet Online.